ÀÖÌìÌÃfun88(ÖйúÇø)¹Ù·½ÍøÕ¾

7. RESTRUCTURING, IMPAIRMENT AND PLANT CLOSING COSTSÌý

Ìý

As ofÌý September 30, 2024 and December 31, 2023, accrued restructuring, impairment and plant closing costs by type of cost consisted of the following (dollars in millions):

Ìý

Ìý

As ofÌý September 30, 2024 and December 31, 2023, accrued restructuring, impairment and plant closing costs by segment consisted of the following (dollars in millions):

Ìý

Ìý

Details with respect to cash and noncash restructuring charges from continuing operations for theÌýthree and nine months ended September 30, 2024 and 2023 are provided below (dollars in millions):

Ìý

Ìý

Restructuring Activities

Ìý

Beginning in the first quarter of 2024, our Advanced Materials segment implemented a restructuring program to optimize the segment’s manufacturing processes and cost structure in the U.S. to better align with future market opportunities. In connection with this restructuring program, we recorded net restructuring expense of approximately $12Ìýmillion inÌýtheÌýnine months ended September 30, 2024, primarily related to workforce reductions and accelerated depreciation. We expect to record further restructuring expenses of approximately $8Ìýmillion through 2026, primarily related to accelerated depreciation.

Ìý

Beginning in the fourth quarter of 2022, we implemented a restructuring program to further realign our cost structure with additional restructuring in Europe. This program is associated with all of our segments and includes exiting and consolidating certain facilities, workforce relocation to lower cost locations and further personnel rationalization. In connection with this restructuring program,Ìýwe recorded net restructuring expense of approximately $4Ìýmillion in the nine months ended September 30, 2024,Ìýprimarily related to site closures.ÌýDuring the nineÌýmonths endedÌý September 30, 2023, we recorded a net restructuring expense of approximately $2Ìýmillion, primarily related to workforce reductions and accelerated depreciation, partially offset byÌýadjustments to restructuring reserves that were no longer required for certain workforce reductions.ÌýWe expect to record further restructuring expenses of approximately $1Ìýmillion through the first half of 2025.

Ìý

Beginning in the first quarter of 2021, our Corporate function implemented aÌýrestructuring program to optimize our global approach to leveraging shared services capabilities. During the second quarter of 2022, this program was further expanded to include additional geographies. During the nineÌýmonths endedÌý September 30, 2023, we evaluated the then current developments of this program and related anticipated cash costs, and we recorded a net restructuring credit of approximately $6Ìýmillion, primarily to adjust restructuring reserves that were no longer required for certain workforce reductions. We do not expect to record any further significant restructuring expenses.

Ìý

Beginning in the second quarter of 2020, our Advanced Materials segment implemented restructuring programs in connection with our 2020 acquisition of CVC Thermoset Specialties,Ìýthe alignment of the segment’s commercial organization and optimization of the segment’s manufacturing processes. In connection with these restructuring programs, we recorded net restructuring expense of approximately $4ÌýmillionÌýinÌýtheÌýnineÌýmonths endedÌý September 30, 2023,Ìýprimarily related to a site closure and accelerated depreciation.Ìý

Ìý

Beginning in the third quarter of 2020, our Polyurethanes segment implemented a restructuring program to optimize its downstream footprint. During the second quarter of 2022, this optimization program was further expanded to include the entire Polyurethanes business. In connection with this restructuring program, we recorded net restructuring expense of approximately $5Ìýmillion inÌýtheÌýnineÌýmonths endedÌý September 30, 2023, primarily related to workforce reductions.Ìý

Ìý